Oligodendrocyte Development and Regenerative Therapeutics in Multiple Sclerosis
Myelination by oligodendrocytes (OLs) is an important biological process essential for central nervous system (CNS) development and functions. Oligodendroglial lineage cells undergo several morphological and molecular changes at different stages of their lineage progression into myelinating OLs. The...
Main Authors: | Nadjet Gacem, Brahim Nait-Oumesmar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/11/4/327 |
Similar Items
-
Functional Heterogeneity of Mouse and Human Brain OPCs: Relevance for Preclinical Studies in Multiple Sclerosis
by: Ana Bribián, et al.
Published: (2020-06-01) -
Microglial transglutaminase-2 drives myelination and myelin repair via GPR56/ADGRG1 in oligodendrocyte precursor cells
by: Stefanie Giera, et al.
Published: (2018-05-01) -
Oligodendrocytes and Microglia: Key Players in Myelin Development, Damage and Repair
by: Ilias Kalafatakis, et al.
Published: (2021-07-01) -
Editorial: Oligodendrocytes: from their development to function and dysfunction
by: Shingo Miyata, et al.
Published: (2024-03-01) -
Developmental Origin of Oligodendrocyte Lineage Cells Determines Response to Demyelination and Susceptibility to Age-Associated Functional Decline
by: Abbe H. Crawford, et al.
Published: (2016-04-01)